• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Chronic Disease

Age and breast cancer risk factors associated with false-positive mammography results

byCaitlyn HuiandSai Folmsbee
January 11, 2016
in Chronic Disease, Oncology
Reading Time: 2 mins read
Age and breast cancer risk factors associated with false-positive mammography results
Share on FacebookShare on Twitter

1. From a retrospective analysis, rates of false-positive digital mammography results were highest in women aged 40-49, while no significant differences were identified between age groups for rates of false-negative mammography results.

2. Several breast cancer risk factors were associated with higher rates of both false-positive and false-negative mammography results across most age groups.

Evidence Rating Level: 2 (Good)

Study Rundown: The potential harms involved with mammography screening for breast cancer include false-positive and false-negative results, followed by additional screening and biopsies. The authors of this study, therefore, sought to estimate the rates of false-positive and false-negative results, as well as the rates of additional imaging and biopsies, from a retrospective analysis of women who underwent screening. From this, the rates of false-positive results and additional imaging were highest in women aged 40-49, which decreased with increasing age. Rates of false-negative results and biopsy recommendations, in comparison, did not differ greatly among age groups. Several breast cancer risk factors were also found associated with higher rates of false-positive and false-negative results, as well as additional imaging and biopsy. Specifically, a family history of breast cancer, high breast density, and previous benign breast biopsy result were statistically significant risk factors for false positive results across age groups. This study may be limited due to the design of the trial, which estimated these rates on a single round of screening. Therefore, the study does not reflect the potential longitudinal screening experiences of women most common in clinical practice. Overall, the study suggests that age and specific breast cancer risk factors are linked to higher rates of false-positive mammography results and additional imaging.

Click to read the study published today in the Annals of Internal Medicine

Relevant Reading: Consequences of False-Positive Screening Mammograms

RELATED REPORTS

Historical redlining associated with lower breast cancer screening across urban neighborhoods

Susie Wiles’ breast cancer diagnosis drives national screening surge

Notification of breast density is associated with increased anxiety and confusion

In-Depth [retrospective cohort]: In this retrospective analysis, data was collected from the Breast Cancer Surveillance Consortium (BCSC) between 2003 and 2011. Specifically, 405,191 women aged 40 to 89 years that had routine screening were included in the study. If women had completed more than 1 mammography screening during the study period, 1 observation was randomly selected to be included in the calculations in order to reduce potential bias. In the analysis, false-positive results were common in all age groups, but highest among women aged 40-49 years (121.2 per 1000 women [95% CI, 105.6-138.7, p < 0.001]). This rate decreased with increasing age, where only 65.2 per 1000 women aged 80-89 had a false-positive mammography result (95% CI, 58.8-72.2, p < 0.001). False-negative results ranged from 1.0 to 1.5 per 1000 women, but there were no statistically significant differences between age groups. Furthermore, rates of false-positive and false-negative results did not differ in comparisons of time since the last mammography screening.

Image: CC/Wiki

©2016 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: mammography
Previous Post

Proton pump inhibitor use associated with development of chronic kidney disease

Next Post

USPSTF recommends biennial screening mammography in 50 to 74 year-old women

RelatedReports

Oncology

Historical redlining associated with lower breast cancer screening across urban neighborhoods

September 13, 2026
High frequency of germline mutations observed in triple negative breast cancers
All Specialties

Susie Wiles’ breast cancer diagnosis drives national screening surge

September 4, 2026
2 Minute Medicine Rewind March 4, 2019
Chronic Disease

Notification of breast density is associated with increased anxiety and confusion

January 13, 2026
3D mammography (tomosynthesis) enhances accuracy of breast cancer screening
Chronic Disease

Abbreviated MRI is superior to whole-breast ultrasound for detection of cancer in dense breasts

June 25, 2025
Next Post
USPSTF recommends biennial screening mammography in 50 to 74 year-old women

USPSTF recommends biennial screening mammography in 50 to 74 year-old women

Epidural corticosteroid injections provide only short-term radiculopathy pain relief

Education combined with exercise linked to reduction of low-back pain episodes

Molecular testing for Clostridium difficile may not predict disease activity

Frozen fecal microbiota transplantation effective for recurrent Clostridium difficile

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • The rate of urethrocutaneous fistula formation may be similar between caudal and penile blocks
  • 2 Minute Medicine Rewind October 12, 2026
  • Gepotidacin (Blujepa) is safe and effective in women with uncomplicated urinary tract infections
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.